Allied Healthcare Products (NASDAQ:AHPI) and COLOPLAST A/S/ADR (OTCMKTS:CLPBY) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

Valuation and Earnings

This table compares Allied Healthcare Products and COLOPLAST A/S/ADR’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Allied Healthcare Products $31.38 million 0.21 -$2.11 million N/A N/A
COLOPLAST A/S/ADR $2.76 billion 10.01 $585.21 million $0.30 42.67

COLOPLAST A/S/ADR has higher revenue and earnings than Allied Healthcare Products.

Institutional and Insider Ownership

11.2% of Allied Healthcare Products shares are held by institutional investors. Comparatively, 0.1% of COLOPLAST A/S/ADR shares are held by institutional investors. 44.9% of Allied Healthcare Products shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Allied Healthcare Products and COLOPLAST A/S/ADR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Allied Healthcare Products -4.64% -17.53% -12.93%
COLOPLAST A/S/ADR 21.62% 69.30% 33.77%

Analyst Ratings

This is a summary of current ratings for Allied Healthcare Products and COLOPLAST A/S/ADR, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allied Healthcare Products 0 0 0 0 N/A
COLOPLAST A/S/ADR 0 1 0 0 2.00

Risk & Volatility

Allied Healthcare Products has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Comparatively, COLOPLAST A/S/ADR has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500.

Summary

COLOPLAST A/S/ADR beats Allied Healthcare Products on 8 of the 10 factors compared between the two stocks.

Allied Healthcare Products Company Profile

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company's respiratory care/anesthesia products comprise air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products include aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, and portable suction equipment. It also provides medical gas equipment, which comprise construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers medical products that include respiratory/resuscitation products comprising demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products, such as spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. Allied Healthcare Products, Inc. was founded in 1979 and is headquartered in St. Louis, Missouri.

COLOPLAST A/S/ADR Company Profile

Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit to individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as SpeediCath catheters that offer catherisation for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. In addition, it provides wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. It offers disposable products that include prostate catheters and stents used before, during, and after surgery under the Porgès brand; vaginal slings to restore continence; synthetic mesh products to treat weak pelvic floor; and penile implants for men. The company supplies its products to hospitals, institutions, wholesalers, and pharmacies; and directly to users. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Receive News & Ratings for Allied Healthcare Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allied Healthcare Products and related companies with MarketBeat.com's FREE daily email newsletter.